Aktieanalys

Oncopeptides: NICE unable to Recommend Pepaxti in the UK - Redeye

{newsItem.title}

Redeye Publicerad: 25 Apr 10:53

Redeye comments on the decision of NICE not to recommend Pepaxti in the UK, which is not unexpected.

Länk till analysen i sin helhet: https://www.redeye.se/research/998568/oncopeptides-nice-unable-to-recommend-pepaxti-in-the-uk?utm_source=finwire&utm_medium=RSS

Nyheter om Oncopeptides

Läses av andra just nu

Om aktien Oncopeptides

Senaste nytt